A Study to See if a New Type of Imaging Can Help Our Understanding of the Course of Non-small Cell Lung Cancer in Patients Undergoing Treatment With Radiotherapy or Chemoradiotherapy
Locally advanced NSCLC has a poor prognosis with a 5 year overall survival rate of only 15%.
Tumour hypoxia may impact the ability to control NSCLC. Using 18F-FAZA PET, this study will
assess patients for hypoxic treatment. With this information, we can start individualizing
patient treatment to target hypoxia. The relationship between areas of hypoxia (18F-FAZA)
and high glucose utilization (18F-FDG) will also be assessed.
Observational
Observational Model: Cohort, Time Perspective: Prospective
To determine the relationship between hypoxic changes and the early local tumour response after definitive radiotherapy or chemoradiotherapy in NSCLC
2.5 yrs
No
Dr. Wilson Roa, MD
Principal Investigator
wilsonro@cancerboard.ab.ca
Canada: Health Canada
LU-24319
NCT00765986
October 2008
October 2012
Name | Location |
---|